167 related articles for article (PubMed ID: 13677396)
1. Serum concentrations of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal dogs and dogs with acute and chronic renal failure.
Gerber B; Hässig M; Reusch CE
Am J Vet Res; 2003 Sep; 64(9):1161-6. PubMed ID: 13677396
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol in dogs with hypercalcaemia.
Gerber B; Hauser B; Reusch CE
Vet Res Commun; 2004 Nov; 28(8):669-80. PubMed ID: 15609867
[TBL] [Abstract][Full Text] [Related]
3. 1,25-dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction.
Lucas PA; Brown RC; Woodhead JS; Coles GA
Clin Nephrol; 1986 Jan; 25(1):7-10. PubMed ID: 3754187
[TBL] [Abstract][Full Text] [Related]
4. Use of carbamylated hemoglobin concentration to differentiate acute from chronic renal failure in dogs.
Vaden SL; Gookin J; Trogdon M; Langston CE; Levine J; Cowgill LD
Am J Vet Res; 1997 Nov; 58(11):1193-6. PubMed ID: 9361876
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates.
Kamr AM; Dembek KA; Reed SM; Slovis NM; Zaghawa AA; Rosol TJ; Toribio RE
PLoS One; 2015; 10(6):e0127684. PubMed ID: 26046642
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
Lucas PA; Woodhead JS; Brown RC
Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
[TBL] [Abstract][Full Text] [Related]
7. A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure.
Christiansen C; Rødbro P; Naestoft J; Christensen MS
Clin Endocrinol (Oxf); 1981 Sep; 15(3):237-42. PubMed ID: 6273028
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonography of the parathyroid glands as an aid in differentiation of acute and chronic renal failure in dogs.
Reusch CE; Tomsa K; Zimmer C; Hoerauf A; Nett C; Unterer S; Glaus TM; Schlittner E; Pospischil A
J Am Vet Med Assoc; 2000 Dec; 217(12):1849-52. PubMed ID: 11132890
[TBL] [Abstract][Full Text] [Related]
9. Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium.
Chalkley SR; Richmond J; Barltrop D
Occup Environ Med; 1998 Jul; 55(7):446-52. PubMed ID: 9816377
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men.
Barger-Lux MJ; Heaney RP; Dowell S; Chen TC; Holick MF
Osteoporos Int; 1998; 8(3):222-30. PubMed ID: 9797906
[TBL] [Abstract][Full Text] [Related]
11. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of parameters for the differentiation of acute from chronic renal failure in the dog].
Gerber B; Glaus TM; Unterer S; Reusch CE
Schweiz Arch Tierheilkd; 2004 Aug; 146(8):365-73. PubMed ID: 15379169
[TBL] [Abstract][Full Text] [Related]
13. Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism.
Mosekilde L; Charles P; Lindegreen P
Bone Miner; 1989 Mar; 5(3):279-90. PubMed ID: 2720198
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
Soliman E; Canaff L; Fox J; Hendy GN
Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
[TBL] [Abstract][Full Text] [Related]
16. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3.
Halloran BP; Schaefer P; Lifschitz M; Levens M; Goldsmith RS
J Clin Endocrinol Metab; 1984 Dec; 59(6):1063-9. PubMed ID: 6333430
[TBL] [Abstract][Full Text] [Related]
17. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D metabolism and parathyroid function in man.
Mawer EB; Backhouse J; Hill LF; Lumb GA; De Silva P; Taylor CM; Stanbury SW
Clin Sci Mol Med; 1975 May; 48(5):349-65. PubMed ID: 165031
[TBL] [Abstract][Full Text] [Related]
19. Circulating 1,25-dihydroxycholecalciferol after intravenous injections of 1 alpha-hydroxycholecalciferol in patients on regular haemodialysis.
Papapoulos SE; vd Berg H; Frölich M; Valentijn RM
Nephrol Dial Transplant; 1988; 3(5):647-50. PubMed ID: 3146722
[TBL] [Abstract][Full Text] [Related]
20. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
